Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
T cell responses and clinical symptoms among infants with congenital cytomegalovirus infection
Alexandra K. Medoro, … , Oliver Adunka, Masako Shimamura
Alexandra K. Medoro, … , Oliver Adunka, Masako Shimamura
Published September 24, 2024
Citation Information: JCI Insight. 2024;9(18):e171029. https://doi.org/10.1172/jci.insight.171029.
View: Text | PDF
Clinical Research and Public Health Immunology Infectious disease

T cell responses and clinical symptoms among infants with congenital cytomegalovirus infection

  • Text
  • PDF
Abstract

BACKGROUND Congenital cytomegalovirus (cCMV) infection can cause developmental impairment and sensorineural hearing loss (SNHL). To determine the relationship between immune responses to cCMV infection and neurologic sequelae, T cell responses were compared for their connection to clinical symptoms at birth and neurodevelopmental outcomes.METHODS Thirty cCMV-infected and 15 uninfected infants were enrolled in a single-center prospective observational case-control study. T cell pp65-specific cytokine responses; CD57, CD28, and PD-1 expression; and memory subsets were compared.RESULTS Infected neonates (73% symptomatic at birth) lacked pp65-specific cytokine-secreting T cells, with elevated frequencies of CD57+, CD28–, and PD-1+CD8+ T cells and effector memory subsets. Though frequencies overlapped between cCMV symptom groups, asymptomatic infants had higher frequencies of CD57+PD-1+CD8+ T cells. Neonates with subsequent developmental delay lacked detectable CMV-specific T cell responses, with patterns resembling those of uninfected infants. Two children with progressive SNHL had high frequencies of PD-1+CD8+ T cells over the first year compared with children without progressive SNHL.CONCLUSION Similar to published reports, neonatal viral antigen–specific cytokine-secreting T cell responses were not detected, but overall patterns indicate that globally differentiated memory CD8+ T cell populations were induced by cCMV infection, with higher frequencies of terminally differentiated PD-1+CD8+ T cells potentially associated with asymptomatic infection. In this cohort, a lack of in utero T cell differentiation was associated with developmental delay, and high frequencies of PD-1+CD8+ T cells persisted only in children with progressive SNHL. Further work is needed to define the specificity of these T cells and their mechanistic connection to these outcomes.FUNDING This study was funded through an intramural research award at Nationwide Children’s Hospital, the Pediatric Infectious Disease Society Fellowship Award funded by Stanley and Susan Plotkin and Sanofi Pasteur, the Abigail Wexner Research Institute at Nationwide Children’s Hospital, and the Pichichero Family Foundation Vaccines for Children Initiative Research Award from the Pediatric Infectious Diseases Society Foundation.

Authors

Alexandra K. Medoro, Ravi Dhital, Pablo J. Sánchez, Kaitlyn Flint, Brianna Graber, Traci Pifer, Rachelle Crisan, William C. Ray, Christopher C. Phelps, Jonathan R. Honegger, Jing Peng, Ursula Findlen, Prashant Malhotra, Oliver Adunka, Masako Shimamura

×

Figure 2

Global CD8+ T cell differentiation and memory in cCMV-infected infants categorized by clinical symptoms at birth.

Options: View larger image (or click on image) Download as PowerPoint
Global CD8+ T cell differentiation and memory in cCMV-infected infants c...
PBMCs of cCMV-infected (n = 18) or uninfected infants (n = 4) at ≤60 days of age were analyzed by flow cytometry for frequencies of global populations of CD8+ T cells expressing CD57, CD28, PD-1, CD45RO, CCR7, and CD45RA. Uninfected and cCMV-infected groups (A and B) and cCMV-infected individuals grouped by clinical symptoms at birth (C–F) were compared. Sx + CNS, symptomatic with CNS findings (n = 7); Sx no CNS, symptomatic without CNS findings (n = 5); eoSNHL, early onset sensorineural hearing loss (n = 2); Asx, asymptomatic (n = 6). (A) Frequencies of CD57+, CD28–, or PD-1+CD8+ T cells between infants with cCMV infection (n = 18) and uninfected infants (n = 4). (B) Frequencies of naive (CCR7+/CD45RA+), central memory (Tcm; CCR7+/CD45RA–), effector memory (Tem; CCR7–/CD45RA–), and effector memory expressing RA (Temra; CCR7–/CD45RA+) subsets for infants with cCMV (n = 18) and uninfected infants (n = 5). (C) Serum viral loads of infants according to clinical symptom group. (D) Representative flow plots of CD8+ T cells stained for CD57, CD28, and PD-1 for an uninfected infant (stained and unstained to show gating) and then for cCMV-infected infants (stained only) from each clinical symptom group, with aggregated data shown in graphs. (E) Representative flow plots of memory markers CCR7/CD45RA shown for an uninfected infant and cCMV-infected infants from each clinical symptom group, with graph showing proportions of memory subsets by group. (F) Representative flow plots and graphs showing frequencies of PD-1+CD8+ T cells coexpressing either CD45RO or CD57. Comparisons were made using the Mann-Whitney U test (A, B, and D), Kruskal-Wallis test (C and F) with Dunn’s multiple comparisons, or 2-way ANOVA (E). *P < 0.05; **P < 0.01; ns, not significant (P > 0.05).

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts